Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VORTIOXETINE HYDROBROMIDE vs VOXELOTOR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

VORTIOXETINE HYDROBROMIDE vs VOXELOTOR: Safety Overview

Metric VORTIOXETINE HYDROBROMIDE VOXELOTOR
Total FAERS Reports 13,705 21,940
Deaths Reported 400 396
Death Rate 2.9% 1.8%
Hospitalizations 1,741 7,660
Average Patient Age 48.8 yrs 33.5 yrs
% Female Patients 69.5% 61.0%
FDA Approval Date Sep 30, 2013 Dec 17, 2021
Manufacturer Takeda Pharmaceuticals America, Inc. Global Blood Therapeutics, Inc, A sub...
Route ORAL ORAL
Marketing Status Prescription Discontinued